宮友陵
四川大學(xué)華西醫(yī)院胸部腫瘤科
畢業(yè)于四川大學(xué)臨床醫(yī)學(xué)院獲腫瘤學(xué)博士學(xué)位。現(xiàn)在四川大學(xué)華西醫(yī)院腫瘤中心及國(guó)家生物治療重點(diǎn)實(shí)驗(yàn)室工作，主要從事腫瘤的內(nèi)科及放射治療和腫瘤分子生物學(xué)研究，2003年至2005年赴美國(guó)南卡羅萊納州立大學(xué)參與完成NIH腫瘤分子生物學(xué)和分子流行病學(xué)研究。曾經(jīng)參與了國(guó)家自然科學(xué)基金課題《nm23基因逆轉(zhuǎn)肺癌轉(zhuǎn)移表型的實(shí)驗(yàn)研究》和《基因修飾的肺癌樹(shù)突狀細(xì)胞疫苗及其抗癌機(jī)制的研究》項(xiàng)目，負(fù)責(zé)四川省科技廳科技支撐項(xiàng)目《非小細(xì)胞肺癌獲得性耐藥的分子標(biāo)記篩選》和中國(guó)吳階平醫(yī)學(xué)基金會(huì)“阿斯利康腫瘤靶向?qū)ｍ?xiàng)研究基金”項(xiàng)目中的《預(yù)測(cè)gefitinib治療非小細(xì)胞肺癌獲得性耐藥的分子標(biāo)記或分子標(biāo)記群的篩選》課題。 現(xiàn)任職務(wù): 腫瘤中心黨支部組織委員 現(xiàn)任職稱(chēng): 副教授 學(xué)術(shù)任職: 中國(guó)抗癌協(xié)會(huì)肺癌專(zhuān)委會(huì)會(huì)員，中國(guó)抗癌協(xié)會(huì)臨床腫瘤學(xué)協(xié)作中心會(huì)員，國(guó)際肺癌學(xué)會(huì)會(huì)員 科研成果: 1. Wang SC, Gong YL, Xu QF, et al. Impacts of multileaf collimators leaf width on intensity-modulated radiotherapy planning for nasopharyngeal carcinoma: analysis of two commercial Elekta devices. Medical Dosimetry 2011;36:153-159. (通訊作者) 2. Gong YL, Wang SC, Zhou L, et al. Dosimetric comparison using different multileaf collimeters in intensity-modulated radiotherapy for upper thoracic esophageal cancer. Radiation Oncology 2010;5:65. 3. Xiao JH, Zhang H, Gong YL, et al. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning. Radiotherapy and Oncology 2010;96:73-77.(共同第一作者) 4. Zou BW, Xu Y, Li T, Li W, Tang B, Zhou L, Li L, Liu YM, Zhu J, Huang MJ, Wang J, Ren L, Gong YL, et al. A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease. International Journal of Radiation Oncology Biology Physics 2010;77:321-328. 5. Gong YL, Ren L, Zhou L, et al. Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma. Cancer Chemotherapy and Pharmacology 2009;64:327-333. 6. Wang J, Bai S, Chen NY, Xu F, Jiang XQ, Li Y, Xu QF, Shen YL, Zhang H, Gong YL, et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiotherapy and Oncology 2009;90:221-227. 7. 宮友陵, 游昕, 唐亞娟, 等. 肺癌合并醫(yī)院獲得性肺炎患者死亡的危險(xiǎn)因素分析. 中華醫(yī)院感染學(xué)雜志2009;19:766-769. 8. Gong YL, Wang J, Bai S, et al. Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis. Radiation Oncology 2008;3:11. 9. 宮友陵, 蔣曉芹, 李濤,等. 肝臟單個(gè)轉(zhuǎn)移瘤大分割圖像引導(dǎo)放療中6MV-和15MV-X 線(xiàn)放療計(jì)劃的劑量學(xué)比較. 四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版) 2008;39:858-860. 10. 李濤, 宮友陵, 蔣曉芹,等. 腫瘤腹主動(dòng)脈旁淋巴結(jié)轉(zhuǎn)移三維適形和調(diào)強(qiáng)放射治療計(jì)劃的劑量學(xué)比較. 中國(guó)醫(yī)學(xué)物理學(xué)雜志 2008;25:630-633.(通訊作者) 11. Wang J, Gong YL, Bai S, et al. Treatment for spinal metastatic cancer with image guided radiotherapy (IGRT): a pilot study. International Journal of Radiation Oncology Biology Physics 2007;69:S589. 12. 宮友陵, 許峰, 李志平, 等. 同步放化療對(duì)局部晚期鼻咽癌患者營(yíng)養(yǎng)狀況的影響. 中國(guó)腫瘤臨床與康復(fù)2007;14:88-91. 13. 宮友陵, 王瑾. DNA修復(fù)靶向性放射-基因治療研究進(jìn)展. 華西醫(yī)學(xué) 2007;22:213-215. 14. 宮友陵, 許峰, 李志平, 等. 179例肺癌患者院內(nèi)細(xì)菌性肺炎常見(jiàn)病原菌及其耐藥性分析. 華西醫(yī)學(xué) 2006;2:28-30. 15. Gong YL, Zhou QH, Xu F, et al. Superior cava vena syndrome caused by mediastinal tuberculous lymphoadenopathy. Respiratory Medicine Extra 2005;1:151-153. 16. Gong YL, Xie DW, Deng ZL, et al. Vitamin D receptor gene Tru9I polymorphism and risk for incidental sporadic colorectal adenomas. World Journal of Gastroenterology 2005;11:4794-4799.
胸部腫瘤的診斷與治療。?
